Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V
NCT01229397
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
205
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Inflexal V
BIOLOGICAL:
Inflexal V
Sponsor
Crucell Holland BV